The Cabinet of Ministers in Ukraine has approved quotas for the production of various substances, including medical cannabis, for 2026. It marks the first time that the nation’s government has set a quota for the production of medical cannabis-based substances after legalizing cannabis for medical use.

“The Cabinet of Ministers adopted a resolution on the approval of quotas for the production, circulation, import and export of narcotic drugs and psychotropic substances for 2026. The decision was adopted in accordance with current legislation and Ukraine’s international obligations. This was reported by UNN with reference to the Ministry of Health of Ukraine.” reported Ukranian National News.

“For the first time, quotas for medical cannabis-based substances have been determined. They apply to imports for scientific activities, the production of medicines and finished products included in the State Register. Six such substances are currently registered in Ukraine, and another 18 are in the process of registration. The circulation of medical cannabis is monitored through the Unified Accounting, Registration and Control System.” the outlet also reported.

Ukraine’s Parliament first approved medical cannabis reform in December 2023, with President Volodymyr Zelensky signing the measure on February 15th, 2024. Cannabis resin, extracts, and tinctures became excluded from the list of ‘dangerous substances’ in Ukraine under the new policy after it took effect in August 2024.

Another major milestone for Ukraine’s emerging medical cannabis industry came in late September 2024, when policymakers and regulators approved a list of 20 qualifying conditions for suffering patients to gain approval for the country’s medical cannabis program. In June 2025, Ukraine approved its first permit for medical cannabis product imports.